Company news
INVO Fertility, Inc. news in 2025
INVO Fertility, Inc.'s news releases, calls and decks from 2025, newest first.
INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy
December 30, 2025
INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
December 17, 2025
INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
December 2, 2025
INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
November 28, 2025
INVO Fertility Announces a 1: 8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025
November 25, 2025
INVO Fertility Announces Third Quarter 2025 Financial Results
November 17, 2025
INVO Fertility Partners with Heidi Health to Bring AI-Powered Tools to INVO’s Wisconsin Fertility Institute
October 27, 2025
INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
September 29, 2025
INVO Fertility Announces Second Quarter 2025 Financial Results
August 14, 2025
INVO Fertility Announces a 1: 3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025
July 17, 2025
INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing
July 9, 2025
INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute
June 30, 2025
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
June 25, 2025
INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12: 00 p.m. Eastern Time
June 20, 2025
INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute
June 18, 2025
INVO Fertility’s Wisconsin Clinic Recognized on Newsweek’s List of America’s Best Fertility Clinics for 2025
June 16, 2025
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
May 27, 2025
INVO Fertility Announces First Quarter 2025 Financial Results
May 20, 2025
INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA
April 30, 2025
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”
April 23, 2025
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
April 13, 2025
NAYA Announces a 1: 12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025
March 12, 2025
NAYA Biosciences Announces Nomination of New Board Members
February 18, 2025
NAYA Biosciences Announces Pricing of $9.5 Million Public Offering
January 12, 2025
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody
January 5, 2025
Decks in 2025
- Investor Presentation (December 2025)
Investor deck · 26 slides · December 2025
- Investor Presentation (September 2025)
Investor deck · 26 slides · September 2025
- NAYA Biosciences — Investor Presentation (January 2025)
Investor deck · 32 slides · Jan 7, 2025